DNMT1 and prostate carcinoma: Lee et al.’s experimental data showed that the reduction of DNA methyltransferase 1 (DNMT1) expression with 5-azacytidine treatment, a global demethylation agent, could induce EMT, and the cancer stem cell phenotype in prostate cancer cells and in turn promote cancer metastasis (20).